title: Prevalence, treatment and known risk factors of urinary incontinence and overactive bladder in the non-institutionalized Portuguese population.
abstract: OBJECTIVE
  To quantify the prevalence (previous month) of urinary incontinence (UI) and overactive bladder (OAB), to assess its relation with known risk factors and to characterize UI awareness and treatment.
  
  
  METHODS
  Telephone interviews were conducted in 1,934 Portuguese subjects aged > or =40 years. UI was defined according to the International Continence Society definitions. OAB was assessed through the Overactive Bladder Assessment Tool.
  
  
  RESULTS
  The prevalence of UI was 21.4% (95% CI 19.0-23.9) in women, 7.6% (95% CI 4.8-10.4) in men. Diagnosis (ever in life) was reported by 4.5% (95% CI 3.3-5.7) of the participants, from which 73.0% reported to have been treated for UI. OAB was reported by 29.4% (95% CI 26.6-32.2) of women and 35.1% (95% CI 29.6-40.6) of men. Obesity, hysterectomy and asthma in women, and age in men, were significantly associated with the symptoms.
  
  
  CONCLUSIONS
  UI and OAB prevalences were high, but the proportion of individuals aware of their condition was low, emphasizing the need for better information among physicians and general population.
authors.affiliation: Department of Hygiene and Epidemiology, University of Porto Medical School, Porto, Portugal. scorreia@med.up.pt
authors.forename: Sofia
authors.initials: S
authors.lastname: Correia
authors.forename: Paulo
authors.initials: P
authors.lastname: Dinis
authors.forename: Francisco
authors.initials: F
authors.lastname: Rolo
authors.forename: Nuno
authors.initials: N
authors.lastname: Lunet
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011174:Portugal / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D053201:Urinary Bladder, Overactive / Q000453:epidemiology* / Q000628:therapy; D014549:Urinary Incontinence / Q000453:epidemiology* / Q000628:therapy
references.citation: Maturitas. 2005 Jan 10;50(1):58-65
references.pmid: 15590215
references.citation: Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(5):301-19
references.pmid: 11052566
references.citation: Qual Life Res. 2002 Sep;11(6):563-74
references.pmid: 12206577
references.citation: BJU Int. 2009 Oct;104(7):954-9
references.pmid: 19388983
references.citation: J Womens Health (Larchmt). 2003 Sep;12(7):687-98
references.pmid: 14583109
references.citation: BJOG. 2003 Oct;110(10):927-33
references.pmid: 14550363
references.citation: Urology. 1995 Sep;46(3):341-5
references.pmid: 7660509
references.citation: Urology. 2006 Mar;67(3):536-40
references.pmid: 16527574
references.citation: BJU Int. 2004 Feb;93(3):324-30
references.pmid: 14764130
references.citation: Acta Obstet Gynecol Scand. 1999 Jul;78(6):546-51
references.pmid: 10376867
references.citation: J Clin Epidemiol. 1995 Mar;48(3):339-43
references.pmid: 7897455
references.citation: BMC Med Res Methodol. 2007 Jun 26;7:27
references.pmid: 17592653
references.citation: Adv Ther. 2005 Jul-Aug;22(4):381-94
references.pmid: 16418145
references.citation: Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5
references.pmid: 17049716
references.citation: Curr Opin Obstet Gynecol. 2005 Oct;17(5):507-11
references.pmid: 16141765
references.citation: BJU Int. 2003 Dec;92(9):943-7
references.pmid: 14632852
references.citation: World J Urol. 2003 May;20(6):327-36
references.pmid: 12811491
references.citation: Ann Epidemiol. 2007 Sep;17(9):643-53
references.pmid: 17553702
references.citation: J Clin Epidemiol. 2000 Nov;53(11):1150-7
references.pmid: 11106889
references.citation: Neurourol Urodyn. 2002;21(2):167-78
references.pmid: 11857671